Clinical Trial Update: An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating an oral antidiabetic agent for treatment of Type 2 diabetes (non-insulin-dependent).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Oral antidiabetic agent (Phase 2 trial)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 2 | Status: COMPLETED